Norsk Titanium AS: Investor meetings in Oslo on 2 February

31 Jan 2023 07:30 CET

Norsk Titanium AS: Investor meetings in Oslo on 2 February 2023

30 January 2023.

2023 is a pivotal year for Norsk Titanium as it transitions key development
efforts into long-term serial production contracts for deliveries to the
semiconductor, commercial aerospace, and defense industries. As previously
announced, Norsk Titanium continues to evaluate strategic opportunities to
secure long-term funding as it ramps up production during the first half of 2023
and has engaged Carnegie AS and Skandinaviska Enskilda Banken AB (publ) to
assist those efforts.

Norsk Titanium’s President & CEO, Michael Canario, will be hosting meetings with
investors and shareholders on 2 February 2023 in Oslo. Michael will be
discussing the recent successes of Norsk Titanium in its key initiatives and the
exciting outlook in the near future.

Please contact Anne Myren at Carnegie if you would like to join the meeting with
Norsk Titanium’s CEO on 2 February 2023.

Anne Myren
Telephone: +47 22 00 93 74
E-mail: anne.myren@carnegie.no



About Norsk Titanium:

Norsk Titanium is a global leader in metal 3D printing, innovating the future of
metal manufacturing by enabling a paradigm shift to a clean and sustainable
manufacturing process. With its proprietary Rapid Plasma Deposition® (RPD®)
technology and 700 MT of production capacity, Norsk Titanium offers
cost-efficient 3D printing of value-added metal parts to a large addressable
market. RPD® technology uses significantly less raw material, energy, and time
than traditional energy-intensive forming methods, presenting customers with an
opportunity to better manage input costs, logistics, and environmental impact.
RPD® printed parts are already flying on commercial aircraft, and Norsk Titanium
has gained significant traction with large defense and industrial customers.

For the latest news, go to www.norsktitanium.com or follow us on LinkedIn. For
more information, please contact:

John Andersen, Chairman of Norsk Titanium AS
Email: John.Andersen@scatec.no
Tel: +47 90 17 40 80

Mike Canario, President and CEO of Norsk Titanium Email:
Michael.Canario@norsktitanium.com
Tel: +1 518 324 4010

Ashar Ashary, CFO of Norsk Titanium AS
Email: Ashar.Ashary@norsktitanium.com
Tel: +1 518 556 8966


This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements.
PCI Biotech disclaims any obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise.

This announcement is for information purposes only and is not to be relied upon
in substitution for the exercise of independent judgment. It is not intended as
investment advice and under no circumstances is it to be used or considered as
an offer to sell, or a solicitation of an offer to buy any securities or a
recommendation to buy or sell any securities of the company.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site